Skip to main content
Therapeutic Advances in Medical Oncology logoLink to Therapeutic Advances in Medical Oncology
. 2021 Jul 23;13:17588359211036552. doi: 10.1177/17588359211036552

Corrigendum to “Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)”

PMCID: PMC8609564  PMID: 34824634

Rebuzzi SE, Signori A, Banna G, et al. Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study). Ther Adv Med Oncol 2021; 13: 1–13. DOI: 10.1177/17588359211019642

In the above-referenced article, one of the authors’ names was listed incorrectly. The correct author name for ‘Maria Soraru’ is ‘Mariella Sorarù’. This has been corrected in the published version of the article.


Articles from Therapeutic Advances in Medical Oncology are provided here courtesy of SAGE Publications

RESOURCES